On the public citation graph
A new member of the immunoglobulin superfamily—CTLA-4
0 signed · 1264 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4891960openalex-extracted
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model
inferred← citeshttps://doi.org/10.1002/(sici)1096-9896(199710)183:2<182::aid-path918>3.0.co;2-iopenalex-snapshot
In vivo expression of the CTLA4 inhibitory receptor in malignant and reactive cells from Human lymphomas
inferred← citeshttps://doi.org/10.1002/(sici)1097-0134(19990801)36:2<217::aid-prot7>3.0.co;2-xopenalex-snapshot
Design and expression of soluble CTLA-4 variable domain as a scaffold for the display of functional polypeptides
inferred← citeshttps://doi.org/10.1002/(sici)1097-0177(200006)218:2<260::aid-dvdy3>3.0.co;2-9openalex-snapshot
Cellular signaling by neural cell adhesion molecules of the immunoglobulin superfamily
inferred← citeshttps://doi.org/10.1002/(sici)1521-4141(199903)29:03<838::aid-immu838>3.0.co;2-popenalex-snapshot
CTLA4 ligation attenuates AP-1, NFAT and NF-κB activity in activated T cells
inferred← citeshttps://doi.org/10.1002/(sici)1521-4141(199911)29:11<3596::aid-immu3596>3.0.co;2-yopenalex-snapshot
A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells
inferred← citeshttps://doi.org/10.1002/1096-9896(200109)195:1<20::aid-path933>3.0.co;2-qopenalex-snapshot
The immune system and gene expression microarrays - new answers to old questions
inferred← citeshttps://doi.org/10.1002/9780470515525.ch7openalex-snapshot
A Role for CTLA‐4‐Mediated Inhibitory Signals in Peripheral T Cell Tolerance?
inferred← citeshttps://doi.org/10.1002/9781119535331.ch4openalex-snapshot
Modeling Resistance to Immune Checkpoint Blockade
inferred← citeshttps://doi.org/10.1002/9781119824572.ch1openalex-snapshot
The Distinguished History of Immunotherapy Development in Cancer
inferred← citeshttps://doi.org/10.1002/9781444355628.ch28openalex-snapshot
Combination and Adjuvant Therapies to Facilitate the Efficacy of Costimulatory Blockade
inferred← citeshttps://doi.org/10.1002/adtp.202100046openalex-snapshot
Advanced Immunotherapy Approaches for Glioblastoma
inferred← citeshttps://doi.org/10.1002/advs.202520634openalex-snapshot
T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities
inferred← citeshttps://doi.org/10.1002/bab.2081openalex-snapshot
Cardiotoxicity of immune checkpoint inhibitors: An updated review
inferred← citeshttps://doi.org/10.1002/bit.260460502openalex-snapshot
Fluorophore‐labeled carbohydrate analysis of immunoglobulin fusion proteins: Correlation of oligosaccharide content with in vivo clearance profile
inferred← citeshttps://doi.org/10.1002/cac2.12539openalex-snapshot
Immunologic tumor microenvironment modulators for turning cold tumors hot
inferred← citeshttps://doi.org/10.1002/cam4.371openalex-snapshot
CTLA ‐4 blockade with ipilimumab: biology, safety, efficacy, and future considerations
inferred← citeshttps://doi.org/10.1002/chem.200600179openalex-snapshot
An Approach for a Synthesis of Asparagine‐Linked Sialylglycopeptides Having Intact and Homogeneous Complex‐Type Undecadisialyloligosaccharides
inferred← citeshttps://doi.org/10.1002/cncr.23086openalex-snapshot
Targeting cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4)
inferred← citeshttps://doi.org/10.1002/ctd2.187openalex-snapshot
Attenuation of the severity and changes in the microbiota in an animal model of primary biliary cholangitis by FOXP3− regulatory T cells
inferred← citeshttps://doi.org/10.1002/eji.1830181206openalex-snapshot
Human Ig superfamily CTLA‐4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA‐4 cytoplasmic domains
inferred← citeshttps://doi.org/10.1002/eji.1830190409openalex-snapshot
Novel structures CTLA‐2α and CTLA‐2β expressed in mouse activated T cells and mast cells and homologous to cysteine proteinase proregions
inferred← citeshttps://doi.org/10.1002/eji.1830201109openalex-snapshot
Molecular cloning and characterization of WP34, a phosphorylated human lymphocyte differentiation and activation antigen
inferred← citeshttps://doi.org/10.1002/eji.1830230919openalex-snapshot
The B7 adhesion molecule is expressed on activated human T cells: Functional involvement in T‐T cell interactions
inferred← citeshttps://doi.org/10.1002/eji.1830240405openalex-snapshot
Expression and function of the costimulatory molecule B7 on murine Langerhans cells: Evidence for an alternative CTLA‐4 ligand
inferred← citeshttps://doi.org/10.1002/eji.1830240502openalex-snapshot
T cells of staphylococcal enterotoxin B‐tolerized autoimmune MRL‐lpr/lpr mice require co‐stimulation through the B7‐CD28/CTLA‐4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co‐stimulatory signal
inferred← citeshttps://doi.org/10.1002/eji.1830250730openalex-snapshot
Sphingomyelin‐ceramide turnover in CD28 costimulatory signaling
inferred← citeshttps://doi.org/10.1002/eji.1830251112openalex-snapshot
Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule
inferred← citeshttps://doi.org/10.1002/eji.1830261257openalex-snapshot
The role of tyrosine phosphorylation and PTP‐1C in CTLA‐4 signal transduction
inferred← citeshttps://doi.org/10.1002/eji.1830270136openalex-snapshot
CD28‐mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28
inferred← citeshttps://doi.org/10.1002/eji.200940282openalex-snapshot
CTLA4‐Ig inhibits allergic airway inflammation by a novel CD28‐independent, nitric oxide synthase‐dependent mechanism
inferred← citeshttps://doi.org/10.1002/eji.201040416openalex-snapshot
Abrogation of ICOS/ICOS ligand costimulation in NOD mice results in autoimmune deviation toward the neuromuscular system
inferred← citeshttps://doi.org/10.1002/eji.201242529openalex-snapshot
The soluble isoform of CTLA‐4 as a regulator of T‐cell responses
inferred← citeshttps://doi.org/10.1002/eji.201546176openalex-snapshot
Metabolic programming in chronically stimulated T cells: Lessons from cancer and viral infections
inferred← citeshttps://doi.org/10.1002/hed.25716openalex-snapshot
Importance of the immune system in head and neck cancer
inferred← citeshttps://doi.org/10.1002/hep.26067openalex-snapshot
Therapeutic Effect of Cytotoxic T Lymphocyte Antigen 4/Immunoglobulin on a Murine Model of Primary Biliary Cirrhosis
inferred← citeshttps://doi.org/10.1002/hon.2821openalex-snapshot
The tumor microenvironment of lymphomas: Insights into the potential role and modes of actions of checkpoint inhibitors
inferred← citeshttps://doi.org/10.1002/iid3.34openalex-snapshot
Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®
inferred← citeshttps://doi.org/10.1002/ijc.21155openalex-snapshot
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction
inferred← citeshttps://doi.org/10.1002/ijc.32829openalex-snapshot
CTLA4 blockade promotes vessel normalization in breast tumors via the accumulation of eosinophils
inferred← citeshttps://doi.org/10.1002/iub.208openalex-snapshot
Structural immunology and crystallography help immunologists see the immune system in action: How T and NK cells touch their ligands
inferred← citeshttps://doi.org/10.1002/jcp.27816openalex-snapshot
Immune checkpoint blockade opens a new way to cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/mco2.70176openalex-snapshot
Application of Immune Checkpoint Inhibitors in Cancer
inferred← citeshttps://doi.org/10.1002/mdb2.70018openalex-snapshot
Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/med.21530openalex-snapshot
Immunomodulators targeting the PD‐1/PD‐L1 protein‐protein interaction: From antibodies to small molecules
inferred← citeshttps://doi.org/10.1002/mog2.70030openalex-snapshot
Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer Therapeutics
inferred← citeshttps://doi.org/10.1002/msp2.50openalex-snapshot
Update on immunotherapy‐mediated colitis: Clinical features, mechanisms, and management
inferred← citeshttps://doi.org/10.1002/ohn.745openalex-snapshot
Over 132 Years Ago, the Inaugural Immunotherapy Treated Its First Head and Neck Cancer Patient
inferred← citeshttps://doi.org/10.1002/ppul.20432openalex-snapshot
Plasma concentrations of soluble CTLA‐4, CD28, CD80 and CD86 costimulatory molecules reflect disease severity of acute asthma in children
inferred← citeshttps://doi.org/10.1002/smll.202308731openalex-snapshot
Nanoparticles Targeting Lymph Nodes for Cancer Immunotherapy: Strategies and Influencing Factors
inferred← citeshttps://doi.org/10.1006/abio.1999.4095openalex-snapshot
Molecular Weights of CTLA-4 and CD80 by Sedimentation Equilibrium Ultracentrifugation
inferred← citeshttps://doi.org/10.1006/bbrc.2000.2234openalex-snapshot
Tyrosine Phosphatase SHP-2 Binding to CTLA-4: Absence of Direct YVKM/YFIP Motif Recognition
inferred← citeshttps://doi.org/10.1006/cimm.2000.1649openalex-snapshot
A Native Soluble Form of CTLA-4
inferred← citeshttps://doi.org/10.1006/clim.1999.4743openalex-snapshot
Costimulatory Markers in Muscle of Patients with Idiopathic Inflammatory Myopathies and in Cultured Muscle Cells
inferred← citeshttps://doi.org/10.1006/clim.1999.4761openalex-snapshot
Immune Response Enhancement by in Vivo Administration of B7.2Ig, a Soluble Costimulatory Protein
inferred← citeshttps://doi.org/10.1006/clim.2001.5093openalex-snapshot
Costimulation of Memory T-Cells by ICOS: A Potential Therapeutic Target for Autoimmunity?
inferred← citeshttps://doi.org/10.1006/geno.1997.4901openalex-snapshot
Identification, Partial Characterization, and Genetic Mapping of Kinesin-like Protein Genes in Mouse
inferred← citeshttps://doi.org/10.1006/geno.1999.5930openalex-snapshot
Complete Sequence Determination of the Mouse and Human CTLA4 Gene Loci: Cross-Species DNA Sequence Similarity beyond Exon Borders
inferred← citeshttps://doi.org/10.1006/jaut.1999.0343openalex-snapshot
CD69, HLA-DR and the IL-2R Identify Persistently Activated T Cells in Psoriasis Vulgaris Lesional Skin: Blood and Skin Comparisons by Flow Cytometry
inferred← citeshttps://doi.org/10.1006/jaut.1999.0353openalex-snapshot
Cytotoxic T Lymphocyte Antigen 4 (CD152) Regulates Self-Reactive T cells in BALB/c but not in the Autoimmune NOD Mouse
inferred← citeshttps://doi.org/10.1006/jmbi.2001.4703openalex-snapshot
Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains 1 1Edited by I. A. Wilson
inferred← citeshttps://doi.org/10.1006/prep.1999.1093openalex-snapshot
Refolding and Characterization of Recombinant Human Soluble CTLA-4 Expressed in Escherichia coli
inferred← citeshttps://doi.org/10.1006/prep.2002.1616openalex-snapshot
Expression, Refolding, Purification, Molecular Characterization, Crystallization, and Preliminary X-ray Analysis of the Receptor Binding Domain of Human B7-2
inferred← citeshttps://doi.org/10.1007/0-387-32829-7_5openalex-snapshot
Regulation of T Cell-Dependent Humoral Immunity Through CD137 (4-1BB) Mediated Signals
inferred← citeshttps://doi.org/10.1007/16833_2024_258openalex-snapshot
Immune Checkpoint Inhibitors: Novel Therapies and Targets
inferred← citeshttps://doi.org/10.1007/7657_2012_38openalex-snapshot
Immunotherapy of High-Grade Gliomas: Preclinical In Vivo Experiments in Animal Models
inferred← citeshttps://doi.org/10.1007/82_2017_61openalex-snapshot
CTLA-4, an Essential Immune-Checkpoint for T-Cell Activation
inferred← citeshttps://doi.org/10.1007/978-0-387-39926-3_2openalex-snapshot
Genomic Variation and Autoimmune Disease
inferred← citeshttps://doi.org/10.1007/978-0-387-79311-5_6openalex-snapshot
CD28 - OLD DOG, NEW TRICKS: CD28 IN PLASMA CELL/MULTIPLE MYELOMA BIOLOGY
inferred← citeshttps://doi.org/10.1007/978-0-585-31180-7_8openalex-snapshot
Leukocyte Cluster of Differentiation Antigens
inferred← citeshttps://doi.org/10.1007/978-1-4020-6087-8openalex-snapshot
General Principles of Tumor Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-1-4020-6087-8_5openalex-snapshot
Immunomodulatory Molecules of the Immune System
inferred← citeshttps://doi.org/10.1007/978-1-4419-8999-4_16openalex-snapshot
Costimulatory Molecules in T CeII Activation and Transplantation
inferred← citeshttps://doi.org/10.1007/978-1-4614-4732-0_8openalex-snapshot
Immune Co-signaling to Treat Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4614-5456-4_9openalex-snapshot
Targeting CD19 with SAR3419, an anti-CD19-Maytansinoid Conjugate for the Treatment of B Cell Malignancies
inferred← citeshttps://doi.org/10.1007/978-1-4615-5355-7_20openalex-snapshot
Non-Structural Determinants of Immunogenicity and the B Cell Co-Receptors, CD19, CD21, and CD22
inferred← citeshttps://doi.org/10.1007/978-1-4684-6814-4_22openalex-snapshot
Subtractive and Differential Molecular Biology Approaches to Molecules Preferentially Expressed in Cytotoxic and Other T Cells
inferred← citeshttps://doi.org/10.1007/978-1-4899-0274-0_22openalex-snapshot
Regulation of T Cell Activation by CD28 and CTLA4
inferred← citeshttps://doi.org/10.1007/978-1-4939-8958-4_4openalex-snapshot
Monoclonal Antibodies for the Treatment of Melanoma: Present and Future Strategies
inferred← citeshttps://doi.org/10.1007/978-1-4939-9773-2_2openalex-snapshot
Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors
inferred← citeshttps://doi.org/10.1007/978-1-59259-018-6_6openalex-snapshot
Adhesion and Costimulatory Molecules
inferred← citeshttps://doi.org/10.1007/978-1-59259-166-4_9openalex-snapshot
Defects and Amplification of Costimulation Across the Species
inferred← citeshttps://doi.org/10.1007/978-1-59259-222-7_14openalex-snapshot
Antitumor Immunity as Therapy for Human Cancer
inferred← citeshttps://doi.org/10.1007/978-1-59259-325-5_21openalex-snapshot
Cancer Drug Discovery and Development
inferred← citeshttps://doi.org/10.1007/978-1-59259-703-1_39openalex-snapshot
Targeting Costimulatory and Other Signaling Molecules in Murine Lupus
inferred← citeshttps://doi.org/10.1007/978-1-60327-087-8_24openalex-snapshot
Treg, Chemokines, and Other Small Molecules: Role in Metastasis and Its Prevention
inferred← citeshttps://doi.org/10.1007/978-1-60761-980-2_11openalex-snapshot
Negative Regulators in Cancer Immunology and Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-15935-1_5openalex-snapshot
Innate and Adaptive Immune Responses to Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-18797-2_2openalex-snapshot
Non-melanoma Skin Cancer and Cutaneous Melanoma from the Oncological Point of View
inferred← citeshttps://doi.org/10.1007/978-3-030-19922-7_1openalex-snapshot
Overview of the Immune System and Its Pharmacological Targets
inferred← citeshttps://doi.org/10.1007/978-3-030-22094-5_13openalex-snapshot
Primary Immunodeficiencies and Cytokine Storm Syndromes
inferred← citeshttps://doi.org/10.1007/978-3-030-24424-8_7openalex-snapshot
Resistance to Checkpoint Blockade Inhibitors and Immunomodulatory Drugs
inferred← citeshttps://doi.org/10.1007/978-3-030-28891-4_19openalex-snapshot
Novel Techniques and the Future of HIPEC (Immunotherapy, Viral Therapy)
inferred← citeshttps://doi.org/10.1007/978-3-030-30845-2_5openalex-snapshot
The Roles of CD4+ T-Cells in Tumor Immunity
inferred← citeshttps://doi.org/10.1007/978-3-030-50287-4_6openalex-snapshot
Overcoming Cancer Tolerance with Immune Checkpoint Blockade
inferred← citeshttps://doi.org/10.1007/978-3-030-51192-0_73-1openalex-snapshot
Immune Effects of Ablation
inferred← citeshttps://doi.org/10.1007/978-3-030-63369-1_15openalex-snapshot
Immune Checkpoint Inhibitors as an Armor for Targeted Immunotherapy of Colorectal Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_183-1openalex-snapshot
Harnessing the Tumor Microenvironment for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_400-1openalex-snapshot
Novel Methods in Cancer Therapy and Drugs Delivery
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_77-1openalex-snapshot
Melanoma with Brain Metastasis
inferred← citeshttps://doi.org/10.1007/978-3-031-01669-1_2openalex-snapshot
Immune Response and Its Role in Cancer
inferred← citeshttps://doi.org/10.1007/978-3-031-15130-9_150openalex-snapshot
Immunotherapy for Melanoma
inferred← citeshttps://doi.org/10.1007/978-3-031-49762-9_73openalex-snapshot
Immune Effects of Ablation
inferred← citeshttps://doi.org/10.1007/978-3-031-59815-9_14openalex-snapshot
Inborn Errors of Immunity and Cytokine Storm Syndromes
inferred← citeshttps://doi.org/10.1007/978-3-032-00759-9_77openalex-snapshot
Melanoma with Brain Metastasis
inferred← citeshttps://doi.org/10.1007/978-3-032-00767-4_183openalex-snapshot
Harnessing the Tumor Microenvironment for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-032-00771-1_400openalex-snapshot
Novel Methods in Cancer Therapy and Drugs Delivery
inferred← citeshttps://doi.org/10.1007/978-3-319-17807-3_2openalex-snapshot
Role of Co-inhibitory Molecules in Tumor Escape from CTL Attack
inferred← citeshttps://doi.org/10.1007/978-3-319-21100-8_12openalex-snapshot
HPV and Radiation Sensitivity
inferred← citeshttps://doi.org/10.1007/978-3-319-22539-5_9openalex-snapshot
Checkpoint Blockade for the Treatment of Advanced Melanoma
inferred← citeshttps://doi.org/10.1007/978-3-319-29827-6_1openalex-snapshot
Enhancing the Efficacy of Checkpoint Blockade Through Combination Therapies
inferred← citeshttps://doi.org/10.1007/978-3-642-03858-7_6openalex-snapshot
Signaling Amplification at the Immunological Synapse
inferred← citeshttps://doi.org/10.1007/978-3-642-38983-2_4openalex-snapshot
Innate and Adaptive Immune Responses to Cancer
inferred← citeshttps://doi.org/10.1007/978-3-642-50059-6_44openalex-snapshot
A Molecular Characterization of BALB/c Congenic C.D2-Idh-1 b , Lsh r , Rep-1 b , Pep-3 b Mice
inferred← citeshttps://doi.org/10.1007/978-3-642-61115-5_1openalex-snapshot
Analysis of CD28 Interactions with Its Cognate Counter-Receptors CD80 and CD86
inferred← citeshttps://doi.org/10.1007/978-3-642-79414-8_4openalex-snapshot
The Role of CD28 Costimulation in the Generation of Cytotoxic T Lymphocytes
inferred← citeshttps://doi.org/10.1007/978-3-642-79603-6_4openalex-snapshot
Follicular Dendritic Cells: Antigen Retention, B Cell Activation, and Cytokine Production
inferred← citeshttps://doi.org/10.1007/978-3-662-44946-2_6openalex-snapshot
Overcoming Cancer Tolerance with Immune Checkpoint Blockade
inferred← citeshttps://doi.org/10.1007/978-4-431-54789-1_14openalex-snapshot
Animal Models for Primary Biliary Cirrhosis
inferred← citeshttps://doi.org/10.1007/978-4-431-73884-8_7openalex-snapshot
Self and Nonself Recognition by Coreceptors on B Lymphocytes: Regulation of B Lymphocytes by CD19, CD21, CD22, and CD72
inferred← citeshttps://doi.org/10.1007/978-981-10-3978-2_9openalex-snapshot
Immune Checkpoint Blockade and Gastric Cancer
inferred← citeshttps://doi.org/10.1007/978-981-10-6469-2_6openalex-snapshot
Evolving Immunotherapy Approaches for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-981-15-3266-5_14openalex-snapshot
Lysosome as the Black Hole for Checkpoint Molecules
inferred← citeshttps://doi.org/10.1007/978-981-15-3266-5_2openalex-snapshot
Molecular and Cellular Functions of CTLA-4
inferred← citeshttps://doi.org/10.1007/978-981-15-3266-5_5openalex-snapshot
Mechanisms of Resistance to Checkpoint Blockade Therapy
inferred← citeshttps://doi.org/10.1007/978-981-15-6407-9_12openalex-snapshot
Understanding and Targeting Human Cancer Regulatory T Cells to Improve Therapy
inferred← citeshttps://doi.org/10.1007/978-981-16-6379-6_13openalex-snapshot
Role of Cytokines as Immunomodulators
inferred← citeshttps://doi.org/10.1007/978-981-16-8845-4_20openalex-snapshot
Immune Checkpoint Inhibitors in Cancer Therapy: A Ray of Hope
inferred← citeshttps://doi.org/10.1007/978-981-32-9717-3_1openalex-snapshot
Co-signal Molecules in T-Cell Activation
inferred← citeshttps://doi.org/10.1007/978-981-32-9717-3_11openalex-snapshot
Cancer Immunotherapy Targeting Co-signal Molecules
inferred← citeshttps://doi.org/10.1007/978-981-32-9717-3_2openalex-snapshot
The CD28–B7 Family of Co-signaling Molecules
inferred← citeshttps://doi.org/10.1007/978-981-99-3746-2_19openalex-snapshot
Deciphering the Role of Immune-Checkpoint Inhibitors in Lung Cancer Treatment
inferred← citeshttps://doi.org/10.1007/978-981-99-7141-1_15openalex-snapshot
Lung Cancer Therapy: Synergistic Potential of PD-1/PD-L1 and CTLA-4 Inhibitors
inferred← citeshttps://doi.org/10.1007/bf00176684openalex-snapshot
Nucleotide sequence of the ACI rat CTLA-4 molecule
inferred← citeshttps://doi.org/10.1007/bf00191228openalex-snapshot
Cloning and sequencing of the rabbit gene encoding T-cell costimulatory molecules
inferred← citeshttps://doi.org/10.1007/bf00211556openalex-snapshot
Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33?q34
inferred← citeshttps://doi.org/10.1007/bf00211698openalex-snapshot
Cd28 and Ctla-4, two related members of the Ig supergene family, are tightly linked on proximal mouse chromosome 1
inferred← citeshttps://doi.org/10.1007/bf00216628openalex-snapshot
Identification of a cDNA encoding the rat CD28 homologue
inferred← citeshttps://doi.org/10.1007/bf00302874openalex-snapshot
A linkage map of mouse Chromosome 1 using an interspecific cross segregating for the gld autoimmunity mutation
inferred← citeshttps://doi.org/10.1007/bf00353861openalex-snapshot
Localization of growth arrest-specific genes on mouse Chromosomes 1, 7, 8, 11, 13, and 16
inferred← citeshttps://doi.org/10.1007/bf00656504openalex-snapshot
Comparative map for mice and humans
inferred← citeshttps://doi.org/10.1007/bf00778825openalex-snapshot
Comparative map for mice and humans
inferred← citeshttps://doi.org/10.1007/bf02171745openalex-snapshot
Immunosuppression and the CD28 receptor
inferred← citeshttps://doi.org/10.1007/bf02199808openalex-snapshot
Cattle CTLA-4, CD28 and chicken CD28 bind CD86: MYPPPY is not conserved in cattle CD28
inferred← citeshttps://doi.org/10.1007/bf02786473openalex-snapshot
CD28/CTLA-4 and CD80/CD86 families
inferred← citeshttps://doi.org/10.1007/bf02918368openalex-snapshot
Accessory cell-derived signals required for T cell activation
inferred← citeshttps://doi.org/10.1007/s00005-009-0030-0openalex-snapshot
Role of ocular pigment epithelial cells in immune privilege
inferred← citeshttps://doi.org/10.1007/s00005-019-00548-3openalex-snapshot
CTLA-4 Expression Inversely Correlates with Kidney Function and Serum Immunoglobulin Concentration in Patients with Primary Glomerulonephritides
inferred← citeshttps://doi.org/10.1007/s00005-021-00618-5openalex-snapshot
CTLA-4 Expression and Its Clinical Significance in Breast Cancer
inferred← citeshttps://doi.org/10.1007/s001090050195openalex-snapshot
The potential for antitumor vaccination in acute myelogenous leukemia
inferred← citeshttps://doi.org/10.1007/s001090050358openalex-snapshot
T cell mediated immunotherapy for B cell lymphoma
inferred← citeshttps://doi.org/10.1007/s00259-014-2944-yopenalex-snapshot
Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study
inferred← citeshttps://doi.org/10.1007/s00259-017-3870-6openalex-snapshot
Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab
inferred← citeshttps://doi.org/10.1007/s00259-022-06084-1openalex-snapshot
Positron emission tomography molecular imaging to monitor anti-tumor systemic response for immune checkpoint inhibitor therapy
inferred← citeshttps://doi.org/10.1007/s00262-003-0424-5openalex-snapshot
Modulation of costimulation to enhance tumor immunity
inferred← citeshttps://doi.org/10.1007/s00262-005-0668-3openalex-snapshot
CTLA-4 blockade augments human T lymphocyte-mediated suppression of lung tumor xenografts in SCID mice
inferred← citeshttps://doi.org/10.1007/s00262-005-0674-5openalex-snapshot
Development of a whole cell vaccine for acute myeloid leukaemia
inferred← citeshttps://doi.org/10.1007/s00262-014-1570-7openalex-snapshot
Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy
inferred← citeshttps://doi.org/10.1007/s00262-018-2183-3openalex-snapshot
Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT
inferred← citeshttps://doi.org/10.1007/s00262-020-02520-zopenalex-snapshot
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model
inferred← citeshttps://doi.org/10.1007/s00281-003-0154-yopenalex-snapshot
The role of ICOS and other costimulatory molecules in allergy and asthma
inferred← citeshttps://doi.org/10.1007/s00281-009-0190-3openalex-snapshot
Costimulation of Th17 cells: adding fuel or putting out the fire in the inflamed gut?
inferred← citeshttps://doi.org/10.1007/s004030000161openalex-snapshot
In situ expression of the CTLA-4 receptor in T-cell-mediated inflammatory and neoplastic skin diseases
inferred← citeshttps://doi.org/10.1007/s00417-007-0606-5openalex-snapshot
Prolongation of corneal allograft survival by CTLA4-FasL in a murine model
inferred← citeshttps://doi.org/10.1007/s00432-015-1915-4openalex-snapshot
Association between co-inhibitory molecule gene tagging single nucleotide polymorphisms and the risk of colorectal cancer in Chinese
inferred← citeshttps://doi.org/10.1007/s00432-023-05152-9openalex-snapshot
Advances in bio-immunotherapy for castration-resistant prostate cancer
inferred← citeshttps://doi.org/10.1007/s10120-014-0440-5openalex-snapshot
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer
inferred← citeshttps://doi.org/10.1007/s10147-023-02430-xopenalex-snapshot
Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1
inferred← citeshttps://doi.org/10.1007/s10157-007-0019-0openalex-snapshot
Clinical manifestations and analyses of the cytotoxic T-lymphocyte associated-4 gene in two Japanese families with systemic lupus erythematosus
inferred← citeshttps://doi.org/10.1007/s10165-005-0452-4openalex-snapshot
T-cell activation via CD26 and caveolin-1 in rheumatoid synovium
inferred← citeshttps://doi.org/10.1007/s10238-022-00887-0openalex-snapshot
The new progress in cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s10529-012-1026-0openalex-snapshot
Generation and evaluation of the efficacy of rhesus monkey soluble cytotoxic T lymphocyte-associated antigen-4 in the allogeneic mixed lymphocyte reaction
inferred← citeshttps://doi.org/10.1007/s10620-023-08007-yopenalex-snapshot
Very Unstable Genetics: How the Confluence of Microsatellite Instability and Immunotherapy Revolutionized the Treatment of Colon Cancer
inferred← citeshttps://doi.org/10.1007/s10637-020-00952-zopenalex-snapshot
Integrative analysis of key candidate genes and signaling pathways in autoimmune thyroid dysfunction related to anti-CTLA-4 therapy by bioinformatics
inferred← citeshttps://doi.org/10.1007/s10753-023-01830-5openalex-snapshot
The Expression of CTLA-4 in Breast Tumors and Tumor-Infiltrating Leukocytes Affects Patients’ Systemic Inflammatory Status and Varies According to Their Molecular Subtypes
inferred← citeshttps://doi.org/10.1007/s10875-006-9049-8openalex-snapshot
CTLA-4 Gene Exon-1 +49 A/G Polymorphism: Lack of Association with Autoimmune Disease in Patients with Common Variable Immune Deficiency
inferred← citeshttps://doi.org/10.1007/s11033-012-1788-4openalex-snapshot
Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis
inferred← citeshttps://doi.org/10.1007/s11060-015-1747-8openalex-snapshot
The role of checkpoints in the treatment of GBM
inferred← citeshttps://doi.org/10.1007/s11060-017-2390-3openalex-snapshot
Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma
inferred← citeshttps://doi.org/10.1007/s11064-024-04121-zopenalex-snapshot
Effect of CTLA-4 Inhibition on Inflammation and Apoptosis After Spinal Cord Injury
inferred← citeshttps://doi.org/10.1007/s11427-018-9409-7openalex-snapshot
Nobel goes to immune checkpoint—Innovative cancer treatment by immunotherapy
inferred← citeshttps://doi.org/10.1007/s11523-021-00840-3openalex-snapshot
The Status of Adjuvant and Neoadjuvant Melanoma Therapy, New Developments and Upcoming Challenges
inferred← citeshttps://doi.org/10.1007/s11684-023-1025-7openalex-snapshot
Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies
inferred← citeshttps://doi.org/10.1007/s11812-019-00096-yopenalex-snapshot
Nebenwirkungen nach Immuntherapie in der Hämatologie und Onkologie
showing the first 200 of 1264 · page through all 1264
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.